Related Experiment Videos
IgA level is associated with risk for mortality in an eighty-year-old population
Takehiro Torisu1, Yutaka Takata, Toshihiro Ansai
1Division of General Internal Medicine, Department of Health Promotion, Kyushu Dental College, Kokurakita-ku, Kitakyushu, Japan. r07torisu@fa.kyu-dent.ac.jp
Elevated immunoglobulin A (IgA) levels in older adults predict higher mortality, particularly cancer mortality in men. This finding highlights IgA as a potential biomarker for mortality risk in elderly males.
Area of Science:
- Gerontology
- Immunology
- Epidemiology
Background:
- Immunoglobulin levels naturally increase with age in older populations.
- The relationship between elevated immunoglobulin levels and mortality risk in the elderly remains unclear.
Purpose of the Study:
- To investigate the association between serum immunoglobulin levels and all-cause mortality in elderly individuals.
- To determine if specific immunoglobulin types predict mortality risk.
Main Methods:
- A cohort of 697 eighty-year-old Japanese individuals was followed for 4 years.
- Serum immunoglobulin A (IgA), IgM, and IgG levels were measured at baseline.
- Kaplan-Meier and multivariate Cox regression analyses were used to assess mortality risk.
Main Results:
- Individuals with high serum IgA levels (>400 mg/dl) exhibited significantly higher mortality.
- Elevated IgA was an independent predictor of mortality (HR=1.233, p=0.031), especially in males.
- IgA levels were specifically associated with increased cancer mortality risk in males, but not with pneumonia or cardiovascular disease mortality. IgM and IgG levels showed no association with mortality.
Conclusions:
- Serum IgA levels serve as a significant predictor of mortality in the elderly.
- The association between high IgA and mortality is particularly pronounced for cancer mortality in males.
- These findings suggest IgA as a potential biomarker for identifying elderly males at higher risk of mortality.
Related Concept Videos
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Drug Dosing: Geriatric Patients
Pharmacodynamics in Geriatric Patients: Effects of Age
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...